Robert Tighe

Robert Tighe

Company: TCR2 Therapeutics

Job title: Vice President - Research


Evaluating & Utilizing Combinations or Co-Stimulatory Molecules to Boost Therapy Durability 11:00 am

Exploring the range of possible combination therapies Administering immune checkpoint inhibitors to accelerate tumor killing Proving chosen combinations are safe to administer to patientsRead more

day: Conference Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.